4.7 Article

Mitochondrial carrier homolog 2 is necessary for AML survival

Journal

BLOOD
Volume 136, Issue 1, Pages 81-92

Publisher

AMER SOC HEMATOLOGY
DOI: 10.1182/blood.2019000106

Keywords

-

Categories

Funding

  1. Canadian Institutes of Health Research
  2. Ontario Institute for Cancer Research
  3. Ontario Ministry of Research and Innovation
  4. Princess Margaret Cancer Centre Foundation
  5. Ministry of Long Term Health and Planning in the Province of Ontario
  6. Leukemia and Lymphoma Society of Canada
  7. Barbara Baker Chair in Leukemia and Related Diseases

Ask authors/readers for more resources

Through a clustered regularly insterspaced short palindromic repeats (CRISPR) screen to identify mitochondrial genes necessary for the growth of acute myeloid leukemia (AML) cells, we identified the mitochondrial outer membrane protein mitochondrial carrier homolog 2 (MTCH2). In AML, knockdown of MTCH2 decreased growth, reduced engraftment potential of stem cells, and induced differentiation. Inhibiting MTCH2 in AML cells in- creased nuclear pyruvate and pyruvate dehydrogenase (PDH), which induced histone acetylation and subsequently promoted the differentiation of AML cells. Thus, we have defined a new mechanism by which mitochondria and metabolism regulate AML stem cells and gene expression.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available